Cinchocaine HCl

✨ ‌Dibucaine Hydrochloride (CAS 61-12-1) | High-Purity Local Anesthetic & Sodium Channel Inhibitor‌ ✨

🧪 ‌Product Overview‌

‌Dibucaine Hydrochloride‌ (CAS 61-12-1), also known as ‌Cinchocaine HCl‌, is a potent ‌amide-type local anesthetic‌ and ‌sodium channel blocker‌ with the molecular formula ‌C₂₀H₂₉N₃O₂·HCl‌ and a molecular weight of ‌379.92‌. This white crystalline powder (purity ≥99%) is widely used for its rapid-acting nerve-blocking properties, offering effective pain relief in clinical and research settings. It exhibits strong lipid solubility, enabling deep tissue penetration and prolonged anesthetic effects.

‌Key Functions‌:

• Induces local anesthesia for surgical and diagnostic procedures.

• Inhibits voltage-gated sodium channels in neurophysiological studies.

• Serves as a pharmaceutical intermediate or reference standard.

‌Target Industries‌: Pharmaceutical manufacturing, biomedical research, and clinical applications.

⭐ ‌Key Advantages‌

🏭 ‌Applications‌

• ‌Surgical Anesthesia‌: Topical or injectable formulations for minor procedures.

• ‌Neurological Research‌: Sodium channel inhibition studies in cellular models.

• ‌Pain Management‌: Relief for acute or chronic neuropathic pain.

📊 ‌Quality Assurance‌

• ‌Testing Standards‌: Validated via ‌HPLC, NMR‌, and ‌FTIR‌ spectroscopy.‌

• Packaging‌: Available in ‌1g–25kg‌ customizable batches (aluminum foil bags or bulk drums).

• ‌Storage‌: Sealed in dry, cool conditions to maintain integrity.

📈 ‌Market Insights‌

The global local anesthetics market is projected to grow at ‌5.8% CAGR (2025–2030)‌, driven by rising demand for non-opioid pain management solutions. Dibucaine remains critical in niche neurological research, with ‌Asia-Pacific‌ emerging as a key production hub due to cost-efficient synthesis and advanced R&D infrastructure.